On May 10th, at Foley & Lardner LLP's 2011 Boston Life Sciences conference, I participated on a panel entitled "Match Making: Identifying Partners, Creative Collaborations and Long Term Outcomes." Mike Morency, Ph.D., an Intellectual Property partner in Foley's Boston office moderated the discussion among John A. Delyani, Ph.D., M.B.A., Head, Therapeutic Areas for Strategic Alliances at the Novartis Institute of BioMedical Research, Gerry Brunk, Managing Director at Lumira Capital, and me.
… Continue reading this entry Tags: Acquisitions,Bare-Knuckle Tactics,Epizyme,Investors,IPO,Plexxikon
On Thursday, June 2, 2011, I will be a speaker for an IPO IP Chat Channel webinar: PATENT REISSUE: THE IMPACT OF RECENT DECISIONS BY THE FEDERAL CIRCUIT As summarized in the IP Chat Channel announcement: Two recent decisions by the Federal Circuit regarding reissue proceedings offer help to patentholders, to different degrees. In re … Continue reading this entry Tags: IP Chat Channel,IPO,Reissue,Tanaka